RNAScope has been used to detect PD-L1 RNA and has been compared to other assays such as IHC in various indications including small cell lung cancer (SCLC) [15]; positivity using RNAScope was defined in this study as the presence of 4–10 punctate dots per tumour cell. This evidence concerns the gene CD274 and small cell lung carcinoma.